Skip to content

The clinical study of the poorly differentiated head and neck squamous cell carcinoma

The clinical study of the poorly differentiated head and neck squamous cell carcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONC-16009290
Enrollment
Unknown
Registered
2016-09-28
Start date
2017-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

poorly differentiated head and neck squamous cell carcinoma

Interventions

Stage I, II group 1:Tumer excision + radiotherapy post surgery
Stage I, II group 2:Radical dose of radiotherapy only
Stage III/IV group 1:Induced chemotherapy + surgery + radiotherapy
Stage III/IV group 2:Induced chemotherapy + radiotherapy or Concurrent chemoradiotherapy

Sponsors

Beijing Tongren Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. the patients of poor differentiated HNSCC ; 2. T1-4aN0-2M0; 3. pathological examination: poor differentiated squamous cell carcinoma; 4. initial treatment(primary, without surgery, radiotherapy and chemotherapy); 5. Aged 18-70 years old; 6. KPS>80; 7. hemogram and the function of main organ such as heart, lung, liver and kidney were normal; 8. having the endoscopy, CT and MRI before formed into different groups; 9. sign the informed consent file, good compliance.

Exclusion criteria

Exclusion criteria: 1. uncontrollable epileptic seizure, disorder of central nervous system or unconsciousness cause by psychosis; 2. serious and uncontrollable infection; 3. main organ system failure (including heart ,lung ,liver and kidney); 4. reject training; 5. high and moderate differentiated squamous cell carcinoma.

Design outcomes

Primary

MeasureTime frame
survival rate;

Countries

China

Contacts

Public ContactZhigang Huang

Beijing Tongren Hospital, Capital Medical University

yzh-117@163.com+86 13701208337

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026